Definitive Healthcare Corp. (NASDAQ:DH) Stake Increased by Irenic Capital Management LP

Irenic Capital Management LP raised its stake in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 9.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 7,003,194 shares of the company's stock after purchasing an additional 590,009 shares during the quarter. Definitive Healthcare accounts for 3.1% of Irenic Capital Management LP's portfolio, making the stock its 10th biggest position. Irenic Capital Management LP owned 6.06% of Definitive Healthcare worth $28,783,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Graham Capital Management L.P. increased its holdings in Definitive Healthcare by 58.5% during the 4th quarter. Graham Capital Management L.P. now owns 85,748 shares of the company's stock valued at $352,000 after purchasing an additional 31,651 shares during the period. D. E. Shaw & Co. Inc. grew its position in shares of Definitive Healthcare by 29.5% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 709,769 shares of the company's stock worth $2,917,000 after buying an additional 161,599 shares during the last quarter. Bayesian Capital Management LP bought a new position in shares of Definitive Healthcare during the fourth quarter valued at approximately $41,000. BNP Paribas Financial Markets bought a new position in shares of Definitive Healthcare during the fourth quarter valued at approximately $313,000. Finally, Northern Trust Corp lifted its stake in Definitive Healthcare by 3.2% in the fourth quarter. Northern Trust Corp now owns 497,279 shares of the company's stock worth $2,044,000 after acquiring an additional 15,530 shares during the period. Hedge funds and other institutional investors own 98.67% of the company's stock.

Analyst Upgrades and Downgrades

DH has been the topic of a number of research analyst reports. BTIG Research downgraded shares of Definitive Healthcare from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th. Needham & Company LLC reissued a "hold" rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Barclays lowered their price objective on shares of Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating for the company in a report on Monday, March 3rd. Finally, The Goldman Sachs Group upped their target price on Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a report on Monday. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $5.10.

Definitive Healthcare Stock Down 1.2%

NASDAQ:DH traded down $0.04 during mid-day trading on Friday, hitting $3.28. 557,333 shares of the company's stock were exchanged, compared to its average volume of 822,572. The company has a market cap of $487.54 million, a PE ratio of -1.06, a P/E/G ratio of 4.06 and a beta of 1.48. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. Definitive Healthcare Corp. has a one year low of $2.15 and a one year high of $6.27. The business has a fifty day moving average price of $2.76 and a 200 day moving average price of $3.85.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.05 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.03. The firm had revenue of $59.19 million for the quarter, compared to analysts' expectations of $56.20 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. The business's revenue for the quarter was down 6.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.08 EPS. Equities analysts predict that Definitive Healthcare Corp. will post 0.16 EPS for the current year.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.